ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Mental Health
Aduhelm: What you need to know about the new Alzheimer’s drug
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Nelson Vergel" data-source="post: 202276" data-attributes="member: 3"><p>"Any side effects?</p><p>In two clinical trials, about 40% of clinical trial patients who got the approved dose of Aduhelm developed painful brain swelling. Symptoms included headache, dizziness, visual disturbances, nausea, and vomiting; about 17% to 18% of patients had microhemorrhages, or small bleeds in their brain. Patients will be monitored for brain swelling before their seventh and 12th infusions. If imaging shows severe swelling, treatment can continue “with caution only after a clinical evaluation and a follow-up MRI demonstrates radiographic stabilization,” the label says."</p><p></p><p><a href="https://www.statnews.com/2021/06/07/faqs-what-you-need-to-know-about-the-alzheimers-drug-aduhelm/?utm_source=STAT+Newsletters&utm_campaign=d179320bd2-Daily_Recap&utm_medium=email&utm_term=0_8cab1d7961-d179320bd2-152153234" target="_blank">FAQs: What you need to know about the Alzheimer’s drug Aduhelm</a></p></blockquote><p></p>
[QUOTE="Nelson Vergel, post: 202276, member: 3"] "Any side effects? In two clinical trials, about 40% of clinical trial patients who got the approved dose of Aduhelm developed painful brain swelling. Symptoms included headache, dizziness, visual disturbances, nausea, and vomiting; about 17% to 18% of patients had microhemorrhages, or small bleeds in their brain. Patients will be monitored for brain swelling before their seventh and 12th infusions. If imaging shows severe swelling, treatment can continue “with caution only after a clinical evaluation and a follow-up MRI demonstrates radiographic stabilization,” the label says." [URL='https://www.statnews.com/2021/06/07/faqs-what-you-need-to-know-about-the-alzheimers-drug-aduhelm/?utm_source=STAT+Newsletters&utm_campaign=d179320bd2-Daily_Recap&utm_medium=email&utm_term=0_8cab1d7961-d179320bd2-152153234']FAQs: What you need to know about the Alzheimer’s drug Aduhelm[/URL] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Mental Health
Aduhelm: What you need to know about the new Alzheimer’s drug
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top